Venus Medtech (Hangzhou) Inc.

SZSC:2500 Stock Report

Market Cap: HK$2.5b

Venus Medtech (Hangzhou) Balance Sheet Health

Financial Health criteria checks 4/6

Venus Medtech (Hangzhou) has a total shareholder equity of CN¥3.3B and total debt of CN¥778.7M, which brings its debt-to-equity ratio to 23.4%. Its total assets and total liabilities are CN¥5.0B and CN¥1.7B respectively.

Key information

23.4%

Debt to equity ratio

CN¥778.68m

Debt

Interest coverage ration/a
CashCN¥1.45b
EquityCN¥3.32b
Total liabilitiesCN¥1.68b
Total assetsCN¥5.00b

Recent financial health updates

No updates

Recent updates

Financial Position Analysis

Short Term Liabilities: 2500's short term assets (CN¥2.1B) exceed its short term liabilities (CN¥633.3M).

Long Term Liabilities: 2500's short term assets (CN¥2.1B) exceed its long term liabilities (CN¥1.0B).


Debt to Equity History and Analysis

Debt Level: 2500 has more cash than its total debt.

Reducing Debt: 2500's debt to equity ratio has increased from 20% to 23.4% over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: 2500 has sufficient cash runway for more than a year based on its current free cash flow.

Forecast Cash Runway: Insufficient data to determine if 2500 has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.


Discover healthy companies